| AUCATZYL AUTOLUS LIMITED
2261329 27 Apr 2023 | on 11 Sep 2024 | Class 005 Class 005 Pharmaceutical Products Medical and veterinary preparations for therapeutic purposes; preparations for cell therapy; preparations for gene therapy; preparations for cancer therapies; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; vaccines. | | | INZYL Incyte Holdings Corporation
2047990 20 May 2020 | on 31 Dec 1969 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune disorders, inflammation and inflammatory disorders, hematological disorders, respiratory and infectious diseases, tissue and organ transplant rejection, dermatological disorders, connective tissue disorders, musculo-skeletal disorders, and ophthalmology disorders. Class 044 Class 044 Medical, Beauty & Agricultural Services Providing patients and healthcare professionals with healthcare information regarding diseases, diagnosis and treatment of diseases, medicines, via a website. | | | Reblozyl Celgene Corporation
2029544 10 Mar 2020 | on 19 Jan 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer. | | | REBLOZYL CELGENE CORPORATION
1911773 26 Jul 2018 | on 15 Apr 2021 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; blood tumors | | | REBLOZYL CELGENE CORPORATION
1822212 09 Feb 2017 | on 27 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; blood tumors | | | ABRIZYL NOVARTIS AG
1512641 26 Jan 2011 | on 14 Mar 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of disorders of the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals. | | | JENZYL MERCK SHARP & DOHME CORP.
1494238 31 Aug 2010 | on 18 Sep 2013 | Class 005 Class 005 Pharmaceutical Products Human pharmaceutical preparations for the treatment of cancer. | | | IPMOZYL ASTRAZENECA AB
1396492 22 May 2008 | on 15 Jun 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolism; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, namely peripheral nervous system infections, cranial and spinal nerve diseases and peripheral system movement disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely sexually transmitted diseases, infertility, hormone replacement therapy preparations, contraceptives, inflammatory pelvic diseases, urological diseases and infertility; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the cardiovascular system; pharmaceutical preparations and substances for the treatment of diseases and disorders of the gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, urology and diabetes; pharmaceutical preparations and substances for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; anti-infectives. | | | AROMAZYL PHARMACIA & UPJOHN S.A.
726516 06 Apr 1993 | on 18 Jul 2001 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely products for the treatment of hormone-dependant neoplasms. | | | SEDORZYL FRANK W. HORNER INC.
296441 19 Apr 1966 | on 20 May 1982 | Class 005 Class 005 Pharmaceutical Products A pharmaceutical product, namely, a bronchodilator, expectorant and sedative. | |